Gerresheimer to Invest $180 million to Expand Medical Systems Capacity in USA.

Specifications:

Name:

Gerresheimer to Invest $180 million to Expand Medical Systems Capacity in USA.

Location:

USA

Company:

Gerresheimer

Estimated Cost:

$180 million

Source:

https://www.gerresheimer.com/

Introduction:

Gerresheimer, a prominent global partner and provider of innovative solutions for the pharmaceutical, biotechnology, and cosmetics industries, is investing approximately 166 million euros (USD 180 million) to expand its U.S. production capabilities.

Features:

The company is increasing the production space at its Peachtree City facility in Georgia by approximately 18,000 square meters (194,000 square feet). The $180 million investment will fund the construction and equipping of two new buildings, creating more than 400 new jobs in Peachtree City, where Gerresheimer currently employs around 270 people.

This expansion highlights Gerresheimer’s position as a leading provider of drug delivery systems in North America. The U.S. market is an essential growth area for the company, and the Peachtree City expansion is a critical part of its global capacity growth strategy, supported by long-term contracts with key customers.